These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37437933)
21. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1. Yi L; Ouyang L; Wang S; Li SS; Yang XM J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702 [TBL] [Abstract][Full Text] [Related]
22. THAP9-AS1 promotes nasopharyngeal carcinoma progression through targeted regulation of the miR-185-5p/SOX13 axis. Mo J; Gong Z; Liu H; Zhou L; Zhao Y Physiol Int; 2024 Mar; 111(1):19-34. PubMed ID: 38270621 [TBL] [Abstract][Full Text] [Related]
23. LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A. Dai BQ; Jiang X; Feng LC Kaohsiung J Med Sci; 2021 May; 37(5):361-370. PubMed ID: 33400379 [TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA BBOX1-AS1 promotes the progression of gastric cancer by regulating the miR-361-3p/Mucin 13 signaling axis. Cai T; Peng B; Hu J; He Y Bioengineered; 2022 May; 13(5):13407-13421. PubMed ID: 36700475 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway. Chen G; Sun W; Hua X; Zeng W; Yang L Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577 [TBL] [Abstract][Full Text] [Related]
26. LncRNA SNHG1 promotes nasopharyngeal carcinoma development via targeting miR-424-5p. Zhou Z; Chen Y Histol Histopathol; 2023 Aug; 38(8):953-963. PubMed ID: 36727428 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis. Zhao C; Shi W; Chen M Bioengineered; 2022 Apr; 13(4):11138-11153. PubMed ID: 35506252 [TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis. Liu D; Wang Y; Zhao Y; Gu X BMC Cancer; 2020 Mar; 20(1):178. PubMed ID: 32131767 [TBL] [Abstract][Full Text] [Related]
29. LncRNA ZFPM2-AS1 drives the progression of nasopharyngeal carcinoma via modulating the downstream miR-3612/DTL signaling. Chang X; Jian L Anticancer Drugs; 2022 Jul; 33(6):523-533. PubMed ID: 35276693 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185 [TBL] [Abstract][Full Text] [Related]
31. LncRNA BBOX1-AS1 promotes pituitary adenoma progression via sponging miR-361-3p/E2F1 axis. Wu H; Zhou S; Zheng Y; Pan Z; Chen Y; Wang X Anticancer Drugs; 2022 Aug; 33(7):652-662. PubMed ID: 35324526 [TBL] [Abstract][Full Text] [Related]
32. LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma. Li S; Tang M; Zen N; Liang J; Xing X; Huang D; Liu F; Zhang X Front Oncol; 2022; 12():921929. PubMed ID: 35756672 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of long non-coding RNA XIST suppresses nasopharyngeal carcinoma progression by activating miR-491-5p. Cheng Q; Xu X; Jiang H; Xu L; Li Q J Cell Biochem; 2018 May; 119(5):3936-3944. PubMed ID: 29219216 [TBL] [Abstract][Full Text] [Related]
34. LncRNA IGBP1-AS1 targets miR-150-5p to increase ZEB1 expression in nasopharyngeal carcinoma. Wang LJ; Wang YS; Zhao Y Transl Cancer Res; 2022 Mar; 11(3):530-537. PubMed ID: 35402187 [TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA OIP5-AS1 Promotes the Disease Progression in Nasopharyngeal Carcinoma by Targeting miR-203. Tang J; Fu C; Li Y; Chen S; Jiang X; Xu W; Xie H Biomed Res Int; 2021; 2021():9850928. PubMed ID: 33628831 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Chen Y; Gao H; Li Y Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422 [TBL] [Abstract][Full Text] [Related]
37. LncRNA VPS9D1-AS1 Sponging miR-520a-5p Contributes to the Development of Uterine Corpus Endometrial Carcinoma by Enhancing BIRC5 Expression. Chen L; Shen M Mol Biotechnol; 2022 Dec; 64(12):1328-1339. PubMed ID: 35619019 [TBL] [Abstract][Full Text] [Related]
38. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2). Yao H; Yang L; Tian L; Guo Y; Li Y Cancer Cell Int; 2020; 20():138. PubMed ID: 32368184 [TBL] [Abstract][Full Text] [Related]
39. LncRNA MIR100HG Promotes Cell Proliferation in Nasopharyngeal Carcinoma by Targeting miR-136-5p/IL-6 Axis. Huang X; Zhong H; Cai Y Mol Biotechnol; 2024 May; 66(5):1279-1289. PubMed ID: 38278928 [TBL] [Abstract][Full Text] [Related]
40. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]